Deficiency in immunocompetence of mice cured from large MOPC-315 plasmacytomas by melphalan therapy

Mice cured from large MOPC-315 tumors by a single dose of melphalan, 7.5 mg/kg, were examined for up to 60 days after the drug treatment (71 days after the tumor inoculation) for their ability to respond to mitogenic stimulation, specific and nonspecific antigenic stimulation and for their susceptib...

Ausführliche Beschreibung